A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma

M. G. Bernengo; F. Vanaclocha; M. Duvic; T. Kuzel; F. Kerdel; L. Pinter-Brown; A. Bosly; C. Okada; D. Breneman; P. L. Zinzani; J. Becker; L. Hughey; M. Ardaiz; J. Zain; L. Zhang; S. Hirawat; G. Laird; D. Johnson; H. M. Prince

A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma

M. G. Bernengo, F. Vanaclocha, M. Duvic, T. Kuzel, F. Kerdel, L. Pinter-Brown, A. Bosly, C. Okada, D. Breneman, P. L. Zinzani, J. Becker, L. Hughey, M. Ardaiz, J. Zain, L. Zhang, S. Hirawat, G. Laird, D. Johnson, H. M. Prince

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	44-45
Number of pages	2
Journal	Haematologica Meeting Reports
Volume	2
Issue number	5
State	Published - 2008
Externally published	Yes

ASJC Scopus subject areas

Hematology

Cite this

Bernengo, M. G., Vanaclocha, F., Duvic, M., Kuzel, T., Kerdel, F., Pinter-Brown, L., Bosly, A., Okada, C., Breneman, D., Zinzani, P. L., Becker, J., Hughey, L., Ardaiz, M., Zain, J., Zhang, L., Hirawat, S., Laird, G., Johnson, D., & Prince, H. M. (2008). A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma. Haematologica Meeting Reports, 2(5), 44-45.

Bernengo, MG, Vanaclocha, F, Duvic, M, Kuzel, T, Kerdel, F, Pinter-Brown, L, Bosly, A, Okada, C, Breneman, D, Zinzani, PL, Becker, J, Hughey, L, Ardaiz, M, Zain, J, Zhang, L, Hirawat, S, Laird, G, Johnson, D & Prince, HM 2008, 'A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma', Haematologica Meeting Reports, vol. 2, no. 5, pp. 44-45.

@article{d67f09a35a0c498bab1e2973927ef17d,

title = "A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma",

author = "Bernengo, {M. G.} and F. Vanaclocha and M. Duvic and T. Kuzel and F. Kerdel and L. Pinter-Brown and A. Bosly and C. Okada and D. Breneman and Zinzani, {P. L.} and J. Becker and L. Hughey and M. Ardaiz and J. Zain and L. Zhang and S. Hirawat and G. Laird and D. Johnson and Prince, {H. M.}",

year = "2008",

language = "English (US)",

volume = "2",

pages = "44--45",

journal = "Haematologica Meeting Reports",

issn = "1970-7339",

publisher = "Ferrata Storti Foundation",

number = "5",

}

TY - JOUR

T1 - A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma

AU - Bernengo, M. G.

AU - Vanaclocha, F.

AU - Duvic, M.

AU - Kuzel, T.

AU - Kerdel, F.

AU - Pinter-Brown, L.

AU - Bosly, A.

AU - Okada, C.

AU - Breneman, D.

AU - Zinzani, P. L.

AU - Becker, J.

AU - Hughey, L.

AU - Ardaiz, M.

AU - Zain, J.

AU - Zhang, L.

AU - Hirawat, S.

AU - Laird, G.

AU - Johnson, D.

AU - Prince, H. M.

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=54249166990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249166990&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:54249166990

SN - 1970-7339

VL - 2

SP - 44

EP - 45

JO - Haematologica Meeting Reports

JF - Haematologica Meeting Reports

IS - 5

ER -

A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma

ASJC Scopus subject areas

Other files and links

Cite this